Tag: “Sector”

Aston Martin’s shares skid after it drops sales volume target

British luxury carmaker Aston Martin unnerved investors on Tuesday by leaving out a sales volume target as it stuck to its medium-term financial goals.

Eli Lilly experimental obesity drug could beat rivals in total weight loss for patients

Eli Lilly’s experimental drug helped patients lose up to 24% of their weight after almost a year, the highest reduction seen in the obesity treatment space to date, according to new mid-stage clinical trial results released Monday.

ChargePoint Stock Rises After It Adopts Tesla’s EV Plug. The Standards War Is Won.

EV charging stocks were rallying early Tuesday in response to the latest news about companies switching over to use Tesla -style EV charging plugs.

Shein Could Capture ‘Major Market Share’ in Apparel. It’s a Bad Sign for Other Retailers.

Shein, the fast-fashion e-commerce juggernaut, is poised to keep gobbling up market share in the U.S., according to UBS .

Saudi Investment Fund Buys More Lucid Stock. Shares Rise.

Lucid ‘s largest shareholder is showing growing support for its electric vehicle investment.

Delta lifts profit forecast thanks to strong demand and premium tickets

Delta Air Lines on Tuesday raised its second-quarter forecast and estimated full-year adjusted earnings of $6 a share, at the high end of estimates it gave last April as strong travel demand and trade-ups to more expensive fare classes continue to drive growth.

China’s Baidu claims its Ernie Bot beats ChatGPT on key tests as A.I. race heats up

Baidu said Tuesday the artificial intelligence model underpinning its chatbot outperformed OpenAI’s ChatGPT in several key areas.

Walgreens slashes earnings guidance due to lower consumer spending, drop in Covid care demand

Walgreens Boots Alliance on Tuesday slashed its full-year earnings guidance as it fell short of Wall Street expectations for its fiscal third quarter due to lower consumer spending and a drop in demand for Covid vaccines and testing.

Pfizer scraps one weight loss drug in race to develop Ozempic rival

Pfizer Inc said it is scrapping its once-a-day experimental obesity pill because of concerns about liver safety, but will continue developing its other obesity pill, the twice daily treatment danuglipron, as it races to rival the success of other weight loss treatments.

Aston Martin turns to U.S. EV company Lucid for high-tech help

British luxury carmaker Aston Martin has reached a deal that will give U.S. electric vehicle (EV) maker Lucid Group a 3.7% stake in the company in return for access to its “high performance” technology, Aston Martin said on Monday.

PacWest sells $3.5 bln loan portfolio to asset management firm Ares

PacWest Bancorp said on Monday it was selling a $3.54 billion lender finance loan portfolio to asset management firm Ares Management, in an attempt to boost liquidity at the U.S. regional lender, sending its shares up nearly 5%.

IBM Buys Software Firm Apptio for $4.6 Billion

IBM is buying software company Apptio in a $4.6 billion all-cash deal. The company says the acquisition will advance IBM’s automation capabilities.

Novo Nordisk says obesity pill leads to 15% weight loss; availability ‘to be determined’

Novo Nordisk on Sunday said a late-stage trial found that a high-dose oral version of its drug semaglutide helped overweight or obese adults lose 15% of their body weight, which is in line with recent results for other experimental obesity pills.

Starbucks strike over Pride decor follows LGBTQ anger on hours, benefits

Workers at dozens of U.S. Starbucks locations held strikes on Sunday to express their outrage over accusations by the baristas’ union that managers at several U.S. cafes removed rainbow flags and decorations supporting LGBTQ+ Pride month.

Gilead Gets Positive European Opinion for Additional Indication for Trodelvy

Gilead Sciences has received a positive response from the European Medicines Agency’s Committee for Medicinal Products for Human Use on an additional indication for the use of its antibody-drug conjugate Trodelvy in certain types of pre-treated breast cancer.

Virgin Galactic raises $300 million, seeks another $400 million to expand spacecraft fleet

Virgin Galactic has successfully raised $300 million via an “at the market” offering of common stock, the company disclosed in a securities filing Thursday.

GSK Stock Climbs on Zantac Settlement. Drug Maker Avoids a California Trial.

U.S.-listed shares of GSK were rising in premarket trading Friday after the pharmaceutical company said it reached a first legal settlement over claims that heartburn medication Zantac can cause cancer.

Ford Stock Slips After Report of More Layoffs

Ford Motor Corp. will announce a new round of layoffs of salaried employees as early as next week, The Wall Street Journal reported, citing people familiar with the matter.

3M reaches $10.3 billion settlement over contamination of water systems with ‘forever chemicals’

Chemical manufacturer 3M Co. will pay at least $10.3 billion to settle lawsuits over contamination of many U.S. public drinking water systems with potentially harmful compounds used in firefighting foam and a host of consumer products, the chemical manufacturer said Thursday.

Siemens Energy shares plunge more than 30% as wind turbine worries deepen

Siemens Energy shares plunged 33% on Friday morning after the company scrapped its profit forecast and warned that costly problems at its wind turbine unit could last for years.